Sepsis ICU Gut Microbiome Analysis
Key facts
- Who runs it
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 180 people, planned
- Started
- 15 Oct 2026
- Expected to end
- 30 Dec 2027
- Type of study
- Observational
- Treatments tested
- Naturally Occurring Exposures
- Record updated
- 8 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age ≥18 years
- Receiving care in the ICU at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Suspected or confirmed infection with an acute infection-related increase in the Sequential Organ Failure Assessment (SOFA) score of ≥2 points from baseline, meeting the Sepsis-3 definition
- The research team determines that a spontaneously passed stool sample can be obtained, or a rectal swab can be collected safely, within the permitted baseline sampling window
- Written informed consent is provided by participants who have decision-making capacity. For participants who temporarily lack decision-making capacity because of impaired consciousness, sedation, or critical illness, consent is provided by a legally authorized representative in accordance with applicable law. Once participants regain decision-making capacity, they will be informed again as soon as possible and asked to provide consent for continued participation
Who cannot take part
- Receipt of fecal microbiota transplantation before ICU admission
- Active inflammatory bowel disease, major gastrointestinal surgery, or any other condition within the past 3 months that substantially alters intestinal anatomy and affects interpretation of the study results
- Active gastrointestinal bleeding, severe coagulopathy, anorectal surgery or lesions, or other conditions that make rectal swab collection unsafe, together with inability to obtain a spontaneously passed stool sample within the specified sampling window
- Pregnancy or reasonable grounds for the investigator to suspect pregnancy
- Expected death within 24 hours and inability to complete informed consent and baseline procedures without interfering with emergency care
- Refusal to participate by the participant or their legally authorized representative, or an investigator determination that the participant is unsuitable for enrollment based on safety, adherence, or data validity considerations
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sepsis is a life-threatening condition in which the body's response to an infection damages its own organs. This study aims to understand how the bacteria living in the gut change during sepsis and whether patterns of gut bacteria and chemicals found in stool can help identify patients at greater risk of death or poor recovery.
Read full original descriptionShow less
This observational study plans to enroll approximately 180 adults with sepsis receiving care in the intensive care unit (ICU) at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. All participants will receive usual medical care. The study will not assign experimental treatments or change treatment decisions.
Researchers will collect stool samples or, when stool is unavailable and sampling is safe, rectal swabs. Samples will be collected within the first 48 hours of the study, on days 3-5, on day 7, and near ICU discharge when feasible. Researchers will examine the types and amounts of gut bacteria. Samples from a selected group of participants will also be tested for chemicals related to metabolism. Information about illness severity, medicines, nutrition, and organ support will be collected from medical records.
Participants will be followed for 90 days, using medical records and telephone follow-up. The main clinical outcome is death from any cause within 28 days. Other outcomes include death and unplanned hospital readmission within 90 days. Researchers will assess whether gut bacterial patterns add useful information to routine clinical assessments and compare findings with available data from other sepsis studies.
The group in the trial
- Adult ICU Patients With Sepsis
Treatment: Naturally Occurring Exposures
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sepsis ICU Gut Microbiome Analysis (SIGMA): A Prospective Observational Cohort Study of Gut Microbiota Structure, Functional Metabolic Features, and Composite Biomarkers in Adult ICU Patients
- Record updated
- 8 October 2026